Purchase Order 75N92021P00345

Award Date 9/29/21
Potential Completion Date 9/28/22
Potential Value $727K
Awardee
Biocomx
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
MONARCH BAY, CA 92629, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order for $100,000.00 was awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the Department of Health and Human Services, to Biocomx, a minority-owned non-profit organization. The contract supports the NIBIB's Medical Device Commercialization Entrepreneurial Training program, which aims to assist early-stage biomedical project teams in commercializing their innovations. Biocomx has experience providing a...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $14.9 million firm fixed price purchase order to Biocomx, a division of Biocomx, to provide services in support of the National Institute of Biomedical Imaging and Bioengineering's COVID-19 RADx projects. Specifically, Biocomx will deliver technical assessments and project management services to assist the NIH NIBIB with its coronavirus-related research and development efforts. The place of performance is...
This is a $1,633,610.00 time and materials purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biocomx, a minority-owned nonprofit organization. The contract is part of the NIH's National Institute of Biomedical Imaging and Bioengineering (NIBIB) COVID-19 RADx initiative, which aims to accelerate the development and implementation of rapid innovative diagnostics for COVID-19. Under this contract,...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency, awarded a $5,905,135.00 firm-fixed-price definitive contract to Lab2Market, PBC, a minority-owned and Hispanic American-owned for-profit company, for a Scientific Entrepreneurial C3I Training program. The contract has a total small business set-aside designation and a period of performance through May 22, 2027. The contract aims to develop commercialization and technology transfer skills among...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $13,176.00 firm fixed price purchase order to Biopac Systems, Inc., a for-profit manufacturer and supplier of biomedical research equipment and software, to provide a cardiac bioimpedance system. The contract is set aside for small businesses and will be used to conduct experiments measuring bioimpedance to study blood flow in the Imaging Physics Laboratory. Biopac Systems,...
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $143,242.83 firm fixed price purchase order to Biomomentum Inc., doing business as Entreprises Biomomentum Les, for the purchase of a multi-axial mechanical tester. The place of performance is Bethesda, Maryland. The period of performance is from August 14, 2023 through November 30, 2023. This purchase supports the National Institutes of Health's mission to seek fundamental...
The Department of Veterans Affairs Veterans Health Administration awarded a $210,760.00 firm fixed price purchase order contract to Biocomx, a minority-owned non-profit organization, to provide services under the C3I Program. The C3I Program is designed to assist medical device innovators with the commercialization of biomedical technologies from research to clinical use. Biocomx has extensive experience supporting biomedical technology development and commercialization, including past contracts...
This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $230,620 purchase order to Cimquest Inc. to procure an XM200G 3D printer. As the prime contractor, Cimquest will deliver the requested 3D printing system to support research efforts. Performance will take place at Cimquest's New Jersey facility over approximately two months. No subcontractors or set aside designations were indicated. This award advances the NIH's mission to...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $727,499 firm fixed price purchase order to Biocomx Biocomx Division. The order was issued under a solicitation seeking proposals for a Biomedical Medical Device Commercialization Entrepreneurial Training opportunity. Biocomx will provide virtual training to assist up to 50 entrepreneurs and small businesses over the course of one base year and one option year in advancing the development and commercialization of innovative medical technologies. No set-aside designation applied. The training aims to help participants start new companies and move technologies toward commercialization and clinical use, supporting the National Institutes of Health's goals of stimulating biomedical innovation.

Generated 12/29/23, 2:39 PM